QuidelOrtho Corporation
QuidelOrtho Corporation
QDEL
Valuace
70
Růst
0
Zdraví
62
Cena
$ 20.96
Dnes
--2.18 (-6.16%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.4B
Obrat
3B
Zisk
-1B
Aktiva
6B
Dluh
3B
ROE
0%
ROA
0%
PE
-1
PS
0
Cena 1R
20-46
⌀ Cena
28.22
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
11-02-2026
Poslední dividenda

Profil

QuidelOrtho Corporation se zaměřuje na vývoj a výrobu diagnostických testovacích technologií napříč kontinuitou potřeb testování zdravotní péče. Společnost působí prostřednictvím obchodních jednotek Labs, Transfusion Medicine, Point-of-Care a Molecular Diagnostics. Obchodní jednotka Labs poskytuje laboratorní nástroje a testy klinické chemie, které měří cílové chemické látky v tělesných tekutinách pro hodnocení zdraví a klinické řízení pacientů; laboratorní nástroje a testy imunoanalýzy, které měří bílkoviny, jelikož působí jako antigeny v šíření onemocnění, protilátky v imunitní reakci vyvolané nemocí nebo markery správné funkce a zdraví orgánů; testuje produkty pro detekci a sledování progrese onemocnění napříč spektrem terapeutických oblastí; a specializovaná diagnostická řešení. Obchodní jednotka pro léčivé přípravky pro transfuze nabízí imunohematologické nástroje a testy používané k typizaci krve, aby byla zajištěna kompatibilita mezi pacienty a dárci při transfuzích krve, a dále nástroje a testy pro screening krve a plazmy na infekční onemocnění. Obchodní jednotka Point-of-Care poskytuje testy, které poskytují rychlé výsledky napříč kontinuálním nastavením point-of-care. Obchodní jednotka Molekulární diagnostika nabízí termoklery polymerázové řetězové reakce a analyzátory a amplifikační systémy. Společnost prodává své výrobky přímo koncovým uživatelům prostřednictvím přímého prodeje a prostřednictvím sítě distributorů pro profesionální použití v lékařských ordinacích, nemocnicích, klinických laboratořích, referenčních laboratořích, klinikách urgentní péče, univerzitách, maloobchodních klinikách, lékárnách, wellness screeningových centrech, krevních bankách a dárcovských centrech, jakož i pro individuální, neprofesionální a volně prodejné použití. Působí v Severní Americe, Evropě, na Blízkém východě, v Africe, Číně a mezinárodně. Společnost byla založena v roce 1979 a sídlí v kalifornském San Diegu.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
6600
Založení
1991-02-01
Adresa
9975 Summers Ridge Road
CEO
Brian J. Blaser

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues2,730.22,730.22,782.92,997.83,266.01,698.61,661.7534.9522.3277.7191.6196.1182.6175.4155.7158.6113.3
Cost of Revenues1,456.01,456.01,496.41,503.41,330.0427.7312.8214.1206.6121.673.471.774.267.061.362.952.6
Gross Profit1,274.21,274.21,286.51,494.41,936.01,270.91,348.9320.8315.7156.1118.2124.4108.4108.494.595.760.7
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues723.6699.9613.9692.8707.8727.1637.0711.0742.6744.0
Cost of Revenues403.2364.3339.0349.5381.7374.8361.0378.9422.6375.9
Gross Profit320.4335.6274.9343.3326.1352.3276.0332.1320.0368.1
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0246.8190.595.784.352.651.633.638.735.537.934.227.726.324.6
Selling General & Admin Expenses0.00.00.0763.2621.0259.6200.5163.9153.996.474.977.367.360.151.048.542.4
Depreciation & Amortization442.0442.0453.4457.2260.49.63.751.846.330.89.18.98.88.26.97.16.7
Total Operating Expenses2,193.42,193.43,247.41,355.3956.3355.3284.8216.4205.6130.1122.6121.7114.1102.485.682.073.7
Operating Income-919.2-919.2-1,960.9139.1843.7906.11,060.352.695.99.6-4.42.7-9.24.28.813.7-15.3
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.059.362.4
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0187.6194.1
Depreciation & Amortization112.5112.1110.3107.1109.3113.1116.1114.9115.4113.1
Total Operating Expenses386.71,040.4455.6310.7426.5337.3393.52,090.1246.9315.3
Operating Income-66.3-704.8-180.732.6-100.415.0-117.5-1,758.040.126.3
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income6.20.00.02.21.30.00.00.00.00.00.00.00.00.00.00.20.2
Interest Expense177.6177.6188.3178.975.75.79.614.824.317.611.812.01.80.81.22.12.3
Other Expense-188.5-188.5-170.6-168.2-107.8-5.7-20.024.6-22.5-16.5-11.8-12.0-3.6-1.80.0-0.4-2.3
IBT-1,107.7-1,107.7-2,131.5-29.1735.9900.41,040.377.263.4-8.0-16.2-9.3-11.03.47.611.5-17.4
Income Tax Expense24.124.1-79.5-19.0187.2196.1230.04.3-10.80.1-2.4-3.2-3.9-4.02.63.9-6.1
Net Income-1,131.8-1,131.8-2,052.0-10.1548.7704.2810.372.974.2-8.2-13.8-6.1-7.17.45.07.6-11.3
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income3.10.03.10.00.00.40.50.00.61.3
Interest Expense43.146.146.142.344.749.547.831.836.737.7
Other Expense-46.1-52.1-48.9-41.4-40.5-43.8-45.4-40.9-49.3-41.8
IBT-112.4-756.9-229.6-8.8-140.9-28.8-162.9-1,798.9-9.2-15.5
Income Tax Expense18.3-23.925.83.937.5-8.9-15.2-92.9-16.2-2.8
Net Income-130.7-733.0-255.4-12.7-178.4-19.9-147.7-1,706.07.0-12.7
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-0.15$9.66$16.74$19.24$1.78$1.86$-0.24$-0.42$-0.18$-0.21$0.22$0.15$0.23$-0.39
EPS Diluted$0.00$0.00$0.00$-0.15$9.56$16.43$18.60$1.73$1.74$-0.24$-0.42$-0.18$-0.21$0.21$0.15$0.23$-0.39
Shares Outstanding67.867.867.266.857.442.943.642.039.933.732.733.833.734.933.732.928.6
Diluted Shares Outstanding67.867.867.266.857.442.943.643.142.633.732.734.134.534.933.733.328.6
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.10$-0.19
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.10$-0.19
Shares Outstanding67.868.067.767.567.267.367.166.966.966.9
Diluted Shares Outstanding67.868.067.767.567.267.367.166.967.366.9
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents107.098.3118.9292.9802.8489.952.843.736.1169.5191.5204.09.417.061.36.8
Short Term Investments0.00.048.452.125.80.00.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments107.098.3167.3345.0802.8489.952.843.736.1169.5191.5204.09.417.061.36.8
Accounts Receivable497.3451.3488.4453.9393.8529.2104.976.967.025.018.434.529.932.614.613.5
Inventory602.0533.7577.8524.1198.8113.858.167.467.126.026.424.827.615.514.717.7
Other Current Assets135.0135.677.0252.14.62.21.90.9161.04.94.415.012.711.913.99.7
Total Current Assets1,341.31,218.91,310.51,575.11,440.31,142.4222.2193.4331.2225.4240.7275.178.674.890.656.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents98.1151.7127.198.3143.7107.078.5118.9149.3178.6
Short Term Investments0.00.00.00.00.00.00.048.443.945.1
Total Cash & ST Investments98.1151.7127.198.3143.7107.078.5167.3193.2223.7
Accounts Receivable513.0396.9437.0451.3518.5472.9476.1488.4520.2426.6
Inventory613.8578.7563.2533.7577.0602.0583.1577.8551.7542.2
Other Current Assets141.8154.2130.9135.6173.4159.474.777.0106.2236.2
Total Current Assets1,366.71,281.51,258.21,218.91,412.61,341.31,212.41,310.51,371.31,308.1
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment1,503.91,548.91,613.41,520.0476.8211.0171.973.961.650.952.549.248.134.228.131.8
Goodwill732.5649.52,492.02,476.8337.0337.0337.0337.0337.083.880.780.780.871.071.071.0
Intangible Assets2,836.02,735.62,934.33,123.898.7122.4148.1175.0203.827.631.841.962.360.373.853.7
Long-Term Investments0.521.77.421.037.90.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets250.3249.0179.6122.719.613.57.14.81.60.50.74.61.81.815.32.1
Total Long-Term Assets5,347.95,204.77,252.67,280.7990.1728.8688.6613.0604.0162.9165.8176.4192.9167.3188.3158.6
Total Assets6,689.26,423.68,563.18,855.82,430.41,871.2910.9806.4935.3388.3406.5451.6271.4241.6278.9214.6
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment1,480.31,471.81,564.41,548.91,539.21,503.91,621.81,613.41,541.61,553.6
Goodwill0.0711.1670.9649.5770.6732.5734.82,492.02,442.92,470.9
Intangible Assets2,608.02,660.52,697.92,735.62,795.92,836.02,887.32,934.32,976.53,035.7
Long-Term Investments12.90.00.021.70.00.00.58.011.924.7
Other Long-Term Assets207.2254.2270.2249.0257.1250.8221.6179.0179.2141.2
Total Long-Term Assets4,308.45,097.65,203.45,204.75,388.55,347.95,490.97,252.67,167.87,242.2
Total Assets5,675.16,379.16,461.66,423.66,801.16,689.26,703.38,563.18,539.18,550.3
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable237.4246.0294.8283.3101.586.326.725.227.316.08.712.47.07.95.04.7
Short-Term Debt385.9372.9166.5207.510.07.819.154.420.20.10.60.50.40.40.30.3
Other Current Liabilities269.0341.0324.6439.8210.1239.178.616.618.57.617.917.114.612.82.55.5
Current Liabilities932.4998.8833.81,007.0323.5337.0125.9159.7128.333.630.836.424.023.245.615.8
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable213.7218.8230.9246.0247.2237.4249.6294.8253.0225.9
Short-Term Debt191.8564.2425.0372.9405.1385.9189.9166.5219.3233.7
Other Current Liabilities327.4271.4329.5341.0309.4243.9296.9324.6385.9328.3
Current Liabilities767.91,142.11,047.2998.81,027.3932.4779.8833.8860.0790.0
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt2,207.12,308.52,447.22,617.2128.6100.793.253.2377.3148.3147.3146.75.110.647.979.8
Capital Leases177.8167.2199.5186.4138.6108.599.60.00.04.14.65.15.65.96.36.6
Def. Tax Liability127.976.5192.2213.20.00.00.00.00.40.12.014.96.33.37.02.3
Total Liabilities3,515.73,439.13,557.23,921.2501.0538.5351.0380.8708.1187.6187.8206.547.841.993.5102.1
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt2,652.02,228.52,269.22,308.52,350.62,384.92,422.82,447.22,450.52,489.7
Capital Leases155.5186.4194.5167.2205.3207.2182.0173.2175.9181.2
Def. Tax Liability80.182.878.276.5117.2127.9125.6192.2196.5199.6
Total Liabilities3,638.73,586.43,464.43,439.13,614.43,515.73,395.63,557.23,572.43,547.8
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.0
Retained Earnings334.1135.82,187.82,197.91,649.2945.0134.761.8-12.4-4.39.615.622.715.310.32.7
Comprehensive Income-24.6-36.2-30.0-67.60.4-0.4-0.5-0.1-82.7-0.10.00.00.0-50.9-45.9-42.6
Total Common Equity3,173.52,984.55,005.94,934.61,929.41,332.7559.8425.6227.1200.6218.7245.0223.5199.8185.4112.5
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.10.10.10.10.10.10.10.10.10.1
Retained Earnings-865.3-132.3123.1135.8314.2334.1481.82,187.82,180.82,193.5
Comprehensive Income-19.716.2-23.8-36.2-3.5-24.6-26.2-30.0-53.2-16.3
Total Common Equity2,036.42,792.72,997.22,984.53,186.73,173.53,307.75,005.94,966.75,002.5
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt2,770.82,681.42,614.12,824.7138.6108.5112.3107.6397.4148.4147.9147.25.610.947.979.8
Book Value3,173.52,984.55,005.94,934.61,929.41,332.7559.8425.6227.1200.6218.7245.0223.5199.8185.4112.5
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value2,036.42,792.72,997.22,984.53,186.73,173.53,307.75,005.94,966.75,002.5
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-1,859.4-1,131.8-2,052.0-10.1548.7704.2810.372.974.2-8.2-13.8-6.1-7.17.45.07.6-11.3
Depreciation & Amortization459.5442.0453.4457.2283.654.449.151.846.330.822.823.428.424.723.317.812.3
Stock-Based Compensation46.60.042.151.648.425.421.013.311.79.18.07.46.78.86.67.55.2
Change Working Capital-329.9-125.8-158.7-194.9-53.2-2.8-251.1-15.2-2.3-23.8-7.510.67.1-11.2-15.710.8-17.5
Change In Accounts Receivable-30.3-117.55.4160.0150.2118.9-402.1-36.18.2-42.1-6.316.1-4.52.9-17.98.93.1
Change In Accounts Payable14.140.0-23.43.023.510.452.22.4-0.313.04.3-3.14.4-0.71.5-1.0-2.6
Change In Inventories-220.8-148.3-134.1-211.6-116.9-85.0-54.99.1-4.00.40.9-1.62.9-12.0-1.13.12.4
Other Non-cash Items2,302.6914.51,897.5-23.657.80.020.613.527.019.55.05.03.3-2.1-1.02.01.3
Cash from Operations23.30.00.0280.2885.3805.9629.8134.5136.327.711.836.335.725.719.647.0-10.3
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-130.7-733.0-255.4-12.7-178.4-19.9-147.7-1,706.07.0-12.7
Depreciation & Amortization112.5112.1110.3107.1109.3113.1116.1114.9115.4113.1
Stock-Based Compensation0.010.712.811.69.612.311.29.112.314.1
Change Working Capital129.1-134.8-74.7-45.4-16.39.1-129.7-86.3-45.2-68.7
Change In Accounts Receivable-28.8-113.422.52.2-2.2-16.6-2.226.435.9-90.4
Change In Accounts Payable55.97.6-22.2-1.30.07.0-13.2-10.79.328.7
Change In Inventories-6.6-39.1-49.5-53.1-23.2-15.7-57.5-37.7-65.6-60.0
Other Non-cash Items14.7700.5160.25.1139.5-70.351.91,741.57.1-1.5
Cash from Operations0.00.00.00.00.00.00.00.080.441.5
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-193.4-188.2-195.1-209.3-140.9-292.7-64.9-27.2-31.7-17.5-11.9-17.0-11.2-22.5-27.7-20.8-10.5
Acquisitions-85.86.50.00.0-1,511.40.00.00.00.0-414.2-5.10.00.0-11.4-1.00.0-128.1
Investments-16.70.0-7.2-60.1-63.7-67.40.00.00.00.00.00.00.00.00.00.0-3.0
Sales of Investment87.50.063.178.353.43.80.00.00.00.00.00.00.00.00.00.04.0
Other Investing Activities76.50.00.03.518.436.91.60.0146.60.00.00.00.00.00.10.03.1
Cash from Investing-131.90.00.0-187.6-1,644.2-319.5-63.3-27.2115.0-431.8-17.0-17.0-11.2-33.9-28.6-20.8-134.5
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-45.3-49.26.510.1-47.2-46.5-35.3-66.1-48.6-43.4
Acquisitions0.00.00.00.00.00.00.00.0-85.80.0
Investments0.00.00.00.00.00.00.0-7.2-9.50.0
Sales of Investment0.00.00.00.00.00.00.063.110.014.4
Other Investing Activities0.00.00.00.00.00.00.00.078.87.7
Cash from Investing0.00.00.00.00.00.00.00.0-55.1-21.3
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-279.60.00.0-226.4-2,388.3-0.3-44.0-53.6-201.9-0.1-5.0-0.5-0.4-5.4-38.8-30.3-3.2
Debt Issued353.32,681.467.315.85,074.430.440.258.3-87.9249.15.51.2142.10.01.8-1.583.0
Issuance of Common Stock8.90.00.011.626.47.69.614.817.025.48.62.94.87.94.759.21.2
Repurchase of Common Stock-13.50.00.0-7.2-74.3-103.4-47.9-10.7-4.3-0.5-20.2-30.9-2.0-2.2-3.4-0.6-9.2
Dividends Paid-13.00.00.00.00.00.00.00.00.0-255.00.00.0-172.50.00.00.0-75.0
Other Financing Activities7.60.00.0-43.82,688.2-77.0-48.0-48.8-54.8500.8-0.2-0.2338.21.40.10.0148.9
Cash from Financing37.50.00.0-265.8252.0-173.2-130.3-98.3-244.1270.6-16.8-28.7168.11.8-37.528.362.6
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-53.6-49.0
Debt Issued2,843.851.198.512.8-74.3-15.1158.1-1.424.2-4.6
Issuance of Common Stock0.00.00.00.00.00.00.00.03.50.8
Repurchase of Common Stock0.00.00.00.0-0.90.00.00.0-7.20.0
Dividends Paid0.00.00.00.00.00.00.00.0-13.00.0
Other Financing Activities0.00.00.00.00.00.00.00.012.5-0.5
Cash from Financing0.00.00.00.00.00.00.00.0-57.8-48.7
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-72.071.3-21.0-174.4-508.9312.8437.29.17.6-133.4-22.0-9.4192.5-6.5-46.554.5-82.2
Closing Cash Balance107.0169.898.5119.5293.9802.8489.952.843.736.1169.5191.5200.98.414.961.36.8
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash71.7-53.624.528.7-45.536.528.5-40.4-30.4-29.7
Closing Cash Balance169.898.1151.7127.298.5144.0107.078.5118.9149.9
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-170.1-83.0-112.170.9744.4513.1564.8107.3104.710.2-0.119.324.43.2-8.126.2-20.8
Real Free Cash Flow-216.7-83.0-154.219.3696.0487.7543.894.092.91.1-8.111.917.7-5.6-14.718.7-25.9
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow86.6-94.7-40.375.716.571.4-133.2-66.831.8-1.9
Real Free Cash Flow86.6-105.4-53.164.16.959.1-144.4-75.919.5-16.0
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-0.9-258.71703.4
P/S0.44.367.9
P/B0.53.825.8
P/FCF-132.527.5396.3
Market cap$1.4$2.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %21.9 %0 %
Debt to Income-251.3 %-3367.6 %0 %
Debt to Free cash flow-36459 %296.7 %0 %
Interest expense percentage-19.3 %31.5 %38.7 %
Current ratio1.8 53.3 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-55.6 %2.8 %0 %
ROA-19.9 %3.3 %0 %
CapEx to Revenue2.9 %8.2 %10.6 %
RaD to Revenue0 %13.1 %0 %
ROEM413,666.7 34364

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin46.7 %60.1 %79.8 %
Operating margin-33.7 %10.1 %29.6 %
Net margin-41.5 %1.3 %27.3 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %1.3 %0 %
Dividend payout percentage0 %-91.3 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding67.8 mil 43.4 mil
Employee count6.6 tis 6.8 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader